UNIONDALE, NY / ACCESS Newswire / December 8, 2025 / Marquis Who’s Who, the trusted biographical authority documenting ...

YPrime, a proven leader in clinical trial technology, today announced it has received two distinctions in the 2025 Clinical ...

Examine the rise of personalized and biomarker-driven therapies, the logistical challenges of rare patient populations, and ...

Clinical research is one of the most dynamic and rapidly growing areas within the pharma and biotech industry. As new ...

MediciNova, Inc., a biopharmaceutical company listed on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of ...

New FDA guidance signals a major shift for CAR-T development, calling for randomized trials with standard-of-care control groups and clear evidence of superiority over existing therapies, while ...

As 2026 approaches, the clinical research and development landscape is evolving beyond traditional scientific innovation with ...

At present evidence-based medicine is guided by the rules and regulations particularly of ethics and moral rights given which ...

Innovative outcome measures coupled with a focus on patient-centered clinical differentiation can help the biopharma industry ...

RAISE focuses on improving race and ethnicity data collection to address healthcare disparities and unmet medical needs. The ...

Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...

Medicus Pharma Ltd. (Nasdaq:MDCX) is a precision guided biotech/life sciences company focused on accelerating the clinical ...